Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies

Pediatric Blood & Cancer(2025)10.1002/pbc.32169Source: DataRank Database

Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies is a research paper published in Pediatric Blood & Cancer (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.00)OA: hybridTopics (23)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Aaron Olson ORCID,Kimberly S. Waggie ORCID,Nicolas M. Garcia ORCID,Virginia J. Hoglund ORCID,Stephanie Walter

Live enrichment

PubMed:41299886 PMC:PMC13064547 OpenAlex:https://openalex.org/W4416771790

NCI NIH HHS

Grant: L40 CA264716

NCI NIH HHS

Grant: K12 CA076930

NCI NIH HHS

Grant: R21 CA280139

NCI NIH HHS

Grant: T32 CA009351

Burroughs Wellcome Fund

CURE Childhood Cancer

Andy Hill CARE Fund

Sunbeam Foundation

National Cancer Institute

Sam Day Foundation

FWCI

0.00

Citation Percentile

0.5%

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.32169

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pbc.32169

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.32169

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/pbc.32169

journalhttps://doi.org/10.1002/pbc.32169

Fields of Study

Chemotherapy-induced cardiotoxicity and mitigationAcute Lymphoblastic Leukemia researchCancer Treatment and Pharmacology

MeSH Terms

AnimalsChildDNA DamageDoxorubicinFemaleHumansNeoplasmsAclarubicinXenograft Model Antitumor AssaysMice

Keywords

AclarubicinAnthracyclinePediatric cancerBlood cancerPreclinical testingDaunorubicinCardiotoxicityEpigeneticsAnthracyclinesPreclinical Models

Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies

FAIR Checklist

Authors (16)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)